What is the recommended management of diabetic ketoacidosis in a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Diabetic Ketoacidosis in Children

Initiate continuous IV regular insulin at 0.05–0.1 U/kg/hour WITHOUT an initial bolus, starting 1–2 hours after fluid resuscitation begins, and continue until ketoacidosis fully resolves—not just until glucose normalizes. 1

Initial Assessment & Diagnostic Workup

Obtain STAT laboratory studies including venous blood gas, complete blood count with differential, urinalysis, plasma glucose, BUN, electrolytes, creatinine, calcium, and phosphorus in all children with suspected DKA. 1

Key diagnostic criteria:

  • Blood glucose >250 mg/dL 2
  • Venous pH <7.3 2
  • Serum bicarbonate <15 mEq/L 2
  • Moderate ketonuria or ketonemia 2

Measure β-hydroxybutyrate directly rather than relying on nitroprusside-based urine ketone tests, which only detect acetoacetate and acetone while missing the predominant ketone body. 1

Calculate corrected serum sodium by adding 1.6 mEq/L for each 100 mg/dL increase in glucose above 100 mg/dL to guide fluid selection. 1

Severity classification guides monitoring intensity:

  • Severe DKA (pH <7.0, bicarbonate <10 mEq/L): requires ICU admission with central venous and intra-arterial pressure monitoring due to higher risk of cerebral edema and mortality 1
  • Moderate DKA (pH 7.0–7.24, bicarbonate 10–15 mEq/L) 2
  • Mild DKA (pH 7.25–7.30, bicarbonate 15–18 mEq/L) 2

Fluid Management Protocol

Phase 1: Initial Resuscitation (Hour 0–1)

Begin with 0.9% normal saline at 10–20 mL/kg over the first hour (300–600 mL for a 30-kg child), but do not exceed 50 mL/kg total in the first 4 hours to minimize cerebral edema risk. 1

Phase 2: Ongoing Fluid Therapy (Hours 1–24)

If corrected sodium is normal or elevated, switch to 0.45% NaCl at 4–14 mL/kg/hour (120–420 mL/hour for a 30-kg child). 1

If corrected sodium is low, continue 0.9% NaCl at the same rate. 1

An alternative smooth-rehydration strategy is to provide 1.5 × maintenance fluids (approximately 5 mL/kg/hour for a 30-kg child). 1

Critical monitoring parameter: Serum osmolality should change ≤3 mOsm/kg per hour; check electrolytes, glucose, BUN, creatinine, and osmolality every 2–4 hours. 1

Insulin Therapy

DO NOT give an initial IV insulin bolus in pediatric patients—this is a critical difference from adult protocols and prevents rapid glucose drops that increase cerebral edema risk. 1

Initiate continuous IV regular insulin infusion 1–2 hours after fluid resuscitation at 0.05–0.1 U/kg/hour (approximately 1.5–3 U/hour for a 30-kg child). 1

If plasma glucose fails to drop ≥50 mg/dL in the first hour, confirm adequate hydration and then double the insulin rate hourly until a steady decline is achieved. 1

Continue insulin until ketoacidosis resolves (pH >7.3, bicarbonate ≥15–18 mEq/L, anion gap normalized)—not merely until glucose normalizes, as ketone clearance takes longer than glucose correction. 1

Potassium Management

Add potassium ONLY after urine output is ≥0.5 mL/kg/hour (≥15 mL/hour for a 30-kg child) to confirm adequate renal function. 1

Once urine output is confirmed, add 20–30 mEq/L potassium to IV fluids using a mixture of 2/3 potassium chloride and 1/3 potassium phosphate. 1

Critical pitfall: Total body potassium is depleted by 3–5 mEq/kg in DKA despite normal or elevated initial serum levels, and insulin therapy drives potassium intracellularly, causing rapid decline. 1

Transition to Dextrose-Containing Fluids

When plasma glucose falls to approximately 250 mg/dL, switch to 5% dextrose in 0.45% NaCl (or 0.45–0.75% NaCl based on sodium status) while maintaining potassium supplementation (20–30 mEq/L, 2/3 KCl + 1/3 KPO₄). 1

Continue the insulin infusion at 0.1 U/kg/hour, adjusting dextrose concentration to keep glucose 150–200 mg/dL. 1

Rationale: Both insulin and glucose are required to clear ketones; insulin alone cannot resolve ketonemia without adequate carbohydrate substrate. 1

Monitoring Throughout Treatment

Hourly: Blood glucose and neurological status (mental status, headache, behavioral changes). 1

Every 2–4 hours: Serum electrolytes (Na, K, Cl), venous pH and bicarbonate, BUN, creatinine. 1

Venous pH is sufficient for monitoring—it is typically 0.03 units lower than arterial pH, eliminating the need for repeated arterial blood gases. 1

Cerebral Edema Recognition

Cerebral edema is the most common life-threatening complication of pediatric DKA and occurs more frequently in children than adults. 1

Early warning signs include:

  • Headache
  • Confusion
  • Behavioral changes
  • Declining mental status 1

Prevention strategies:

  • Avoid overly aggressive fluid resuscitation (do not exceed 50 mL/kg in first 4 hours) 1
  • Do not give initial insulin bolus 1
  • Maintain hourly neurological assessments 1

Transition to Subcutaneous Insulin

Once ketoacidosis resolves (pH >7.3, bicarbonate ≥15–18 mEq/L), initiate subcutaneous insulin while continuing IV insulin for 1–2 hours to prevent rebound hyperglycemia. 2

For type 2 diabetes with ketoacidosis: Once acidosis resolves, metformin should be initiated while subcutaneous insulin therapy is continued. 2

For type 1 diabetes or positive pancreatic autoantibodies: Continue or initiate multiple daily injection insulin or pump therapy as for type 1 diabetes; discontinue metformin. 2

Prevention of Recurrent DKA

Provide 24-hour telephone support for families of children with type 1 diabetes. 1

Educate caregivers on early signs of DKA and the importance of ketone monitoring during intercurrent illness. 1

Emphasize that recurrent DKA is almost always due to insulin omission. 1

Offer psychological support, as recurrent DKA is associated with higher rates of psychiatric illness, depression, and eating disorders. 1

References

Guideline

Pediatric Diabetic Ketoacidosis (DKA) Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.